Ask any experienced code team member and they will tell you the same thing: sodium bicarbonate gets pushed during resuscitations far more often than it should. It is one of those drugs that carries the aura of doing something definitive — treating the acidosis, correcting the chemistry, giving the heart a fighting chance. The problem is that for most cardiac arrests, that instinct is wrong, and the evidence has been telling us so for decades.
This article is a peer-level conversation about sodium bicarbonate — what it actually does physiologically, where the myths came from, when current guidelines say it is genuinely indicated, and why indiscriminate use during CPR can make outcomes worse rather than better. Whether you are a nurse, paramedic, resident, or attending who has ever reached for bicarb during a code, this breakdown is worth your time.
To understand why bicarb is so often the wrong choice, you need to understand the physiology. During cardiac arrest, tissue hypoperfusion triggers anaerobic metabolism, producing lactic acid and driving down blood pH. This is real acidosis, and it is genuinely harmful — severe acidosis impairs myocardial contractility, reduces the effectiveness of catecholamines, and lowers the threshold for arrhythmias.
Here is where the logic goes sideways. The intuitive fix seems obvious: if acidosis is bad, neutralize it with a base. Sodium bicarbonate, a strong buffer, should do exactly that. The chemistry is straightforward — bicarbonate combines with hydrogen ions to form water and carbon dioxide. But that carbon dioxide has to go somewhere, and during cardiac arrest, it cannot be exhaled efficiently because pulmonary circulation is severely compromised. Instead, it accumulates.
The result is a paradox that has been documented in multiple studies. Sodium bicarbonate administration during CPR raises arterial pH in the blood, which looks good on a lab value, but simultaneously increases tissue CO2 levels and drives paradoxical intracellular acidosis in the heart and brain. The bicarbonate-generated CO2 diffuses freely across cell membranes into myocardial and cerebral cells, making the intracellular environment more acidic even as the extracellular environment appears more alkaline. According to a comprehensive state-of-the-art review published in PMC, this mechanism is well-established and represents a core reason why routine bicarb use during CPR is physiologically counterproductive.
There are additional adverse effects beyond intracellular acidosis. Sodium bicarbonate creates hyperosmolarity, increases sodium load, shifts the oxyhemoglobin dissociation curve leftward (reducing oxygen release to tissues), reduces ionized calcium levels, and can paradoxically increase systemic vascular resistance in ways that compromise coronary perfusion pressure. The full picture is not a drug that helps the arrested heart — it is a drug that, when given reflexively, adds multiple physiological insults to an already failing system.
Sodium bicarbonate was a standard part of cardiac resuscitation protocols for many years, and that historical legacy has proven remarkably durable. Older providers trained in eras when bicarb was given routinely carry that muscle memory into current practice. Newer providers often see it ordered and assume it must be indicated. Both groups deserve a clearer picture of what the evidence actually shows.
Myth 1: Acidosis during cardiac arrest always needs to be buffered. Lactic acidosis during cardiac arrest is a consequence of inadequate perfusion, not the root cause of cardiac arrest failure. The correct treatment is restoring circulation — excellent CPR, early defibrillation when indicated, and epinephrine. Buffering the blood chemistry without fixing the underlying perfusion problem does not change outcomes. A guidelines and literature review published in PMC found that the majority of studies on sodium bicarbonate in cardiac arrest show no benefit and several show potential harm from routine use.
Myth 2: A low pH on the blood gas means give bicarb. This is one of the most common triggers for reaching for sodium bicarbonate in a code. But pH during active cardiac arrest is almost universally low, and that value does not tell you whether bicarbonate deficiency or CO2 excess is driving it. During CPR, mixed respiratory and metabolic acidosis is the norm. Giving more bicarbonate in the setting of elevated CO2 generates more CO2, worsening the respiratory component. Without knowing the full acid-base picture — which requires adequate ventilation and meaningful perfusion to interpret — pH alone is a poor trigger for bicarb administration.
Myth 3: It cannot hurt to give it. This is perhaps the most dangerous misconception. The adverse effects catalogued above — intracellular acidosis, hyperosmolarity, impaired oxygen delivery, ionized hypocalcemia — are real and dose-dependent. Sodium bicarbonate is not a benign drug when given to a patient in cardiac arrest. The belief that it is a safe default that might help while doing no harm is not supported by the evidence base.
The American Heart Association Adult Advanced Life Support guidelines are explicit on this point: sodium bicarbonate is not recommended for routine use during in-hospital or out-of-hospital cardiac arrest. This recommendation has been consistent across multiple guideline cycles and reflects the convergence of physiological reasoning and clinical evidence. The routine administration of sodium bicarbonate during ACLS is considered of no benefit and potentially harmful in the absence of specific underlying conditions.
The word "routine" is doing important work in that recommendation. The guidelines do not say never give bicarbonate. They say do not give it by default, do not give it simply because the code is ongoing, and do not give it just because the pH looks bad on an ABG. This is a distinction that matters enormously in real code situations, where the urge to do something — to reach for another drug — can be powerful. Understanding the Adult Cardiac Arrest Vertical Algorithm helps frame exactly where medication decisions fit within the larger resuscitation structure, and sodium bicarbonate sits outside the primary algorithm for good reason.
A systematic literature review examining sodium bicarbonate in both in-hospital and out-of-hospital cardiac arrest found that overall, its administration was associated with lower rates of ROSC and worse downstream outcomes when used without specific indication. The studies that have examined sodium bicarbonate in undifferentiated cardiac arrest consistently fail to demonstrate survival benefit and frequently reveal signals of harm.
Here is where the article shifts from myth-busting to practical clinical guidance. There are specific, well-defined situations where sodium bicarbonate is not just permissible but genuinely indicated during cardiac arrest. Knowing these scenarios cold is what separates providers who reflexively reach for bicarb from providers who use it precisely and effectively.
Severe hyperkalemia is one of the most treatable causes of cardiac arrest, and it sits squarely within the H causes in the systematic framework for reversible etiologies. When potassium rises to critically high levels, it destabilizes cardiac membrane potentials, leading to progressive ECG changes — peaked T-waves, widened QRS, sine wave pattern — and ultimately ventricular fibrillation or asystole. Addressing this as part of the Hs and Ts framework is essential for any provider managing a cardiac arrest with suspected metabolic etiology.
Sodium bicarbonate drives potassium intracellularly by creating an alkalotic shift, temporarily lowering serum potassium levels and reducing the degree of membrane destabilization. In a hyperkalemic arrest, this mechanism is clinically meaningful. It buys time, stabilizes the cardiac membrane, and may facilitate ROSC in conjunction with calcium administration — which directly antagonizes the membrane effects of hyperkalemia — and glucose-insulin therapy. The key distinction is that in hyperkalemia, you are using bicarbonate for a specific mechanistic purpose — not buffering nonspecific acidosis, but treating the underlying cause of the arrest. For a fuller picture of all ACLS drug options in this setting, the ACLS Medications Cheat Sheet provides a comprehensive reference for dosages and indications.
Tricyclic antidepressant (TCA) toxicity is another scenario where sodium bicarbonate moves from contraindicated to essential. TCAs cause cardiac toxicity through sodium channel blockade in the cardiac conduction system, leading to widened QRS complexes, right axis deviation, and ultimately ventricular arrhythmias and hemodynamic collapse. The widened QRS is the clinical target.
Sodium bicarbonate treats TCA toxicity through two mechanisms. First, the alkalosis created by bicarbonate increases protein binding of the drug, reducing the amount of free TCA available to block sodium channels. Second, the elevated sodium load from the bicarbonate solution itself helps overcome the sodium channel blockade by increasing the concentration gradient driving sodium into cells. This is a specific pharmacological intervention, not buffering acidosis. The goal is QRS narrowing and hemodynamic stabilization. Sodium bicarbonate is indicated here and should be given aggressively in TCA-induced cardiac arrest or hemodynamic instability.
By extension, the same logic that applies to TCAs applies to other drugs that cause toxicity through sodium channel blockade. This category includes cocaine toxicity with life-threatening arrhythmias, as well as certain other cardiotoxic ingestions. The guidelines acknowledge this as a specific circumstance where bicarb is appropriate during resuscitation. When the arrest is clearly drug-toxicity-driven with suspected sodium channel involvement, sodium bicarbonate is a reasonable and guideline-supported intervention. Understanding the broader landscape of drug comparisons during resuscitation — such as the evidence behind epinephrine versus vasopressin in cardiac arrest — helps frame how each medication serves a distinct mechanistic role in resuscitation.
A patient who arrests with documented, severe pre-existing metabolic acidosis — for example, a patient in diabetic ketoacidosis with documented bicarbonate levels below 10 mEq/L who then arrests — represents a different situation from the typical cardiac arrest patient. Here, the bicarbonate deficit is the underlying problem, not a consequence of the arrest itself. Bicarbonate administration in this context has clear physiological rationale, though even here the evidence base is limited and careful titration is warranted. A double-blind, randomized, placebo-controlled pilot study on bicarbonate during prolonged CPR with severe metabolic acidosis found mixed results, underscoring that even in true metabolic acidosis, the benefit is not guaranteed and careful patient selection matters.
There is emerging and somewhat contradictory observational data worth acknowledging. Some recent registry analyses have suggested an association between prehospital sodium bicarbonate use in pulseless electrical activity and asystole — specifically, improved survival in certain subsets. This is interesting and hypothesis-generating, but it is observational data with significant confounding. Providers who are more experienced or better-resourced may be more likely to give bicarb in certain arrest patterns, creating selection bias that complicates interpretation.
The current guidance has not changed based on this data. PEA and asystole have specific treatable causes that remain the primary focus of resuscitation. The systematic approach to PEA causes and treatment remains anchored in identifying and reversing specific underlying etiologies — not empirical drug administration. If that reversible cause is hyperkalemia, then bicarbonate is indicated for that reason — not simply because the rhythm is PEA.
Translating guideline knowledge into real code decision-making requires a clear mental framework. Here is a practical approach to sodium bicarbonate during any resuscitation:
A comprehensive review of bicarbonate use in common clinical scenarios published in the Journal of Emergency Medicine provides additional decision-support for providers navigating these questions across different clinical contexts — not just cardiac arrest but also other critical care situations where bicarbonate comes up regularly.
Sodium bicarbonate during cardiac arrest is a perfect example of why ACLS education needs to go deeper than algorithm memorization. The algorithms tell you what to do in standard presentations. The pharmacology and physiology tell you how to think when the situation is not standard — when the history suggests a reversible cause, when a drug overdose is on the differential, when the rhythm and clinical picture point toward metabolic crisis rather than primary cardiac disease.
This level of understanding is what separates providers who react during a code from providers who think. And it is absolutely accessible through structured, rigorous ACLS education. At Affordable ACLS, our courses are built by Board Certified Emergency Medicine physicians to reflect exactly this kind of evidence-based, nuance-forward content. The goal is not just to pass a test — it is to make you a better clinician at the bedside, in the code room, and in the moments when the right drug choice actually changes what happens to your patient.
Whether you are preparing for initial ACLS certification at $99 or refreshing your knowledge through our $89 recertification course, the pharmacology modules are designed to answer the why behind every drug in the algorithm — including the ones that should be used selectively, like sodium bicarbonate. The course is 100% online, self-paced, and available the moment you enroll, so you can work through the clinical reasoning at your own speed and on your own schedule.
Sodium bicarbonate is not a bad drug. It is a specific drug used incorrectly far too often. When a patient arrests due to severe hyperkalemia, when TCA toxicity has driven the QRS wide and destabilized the cardiac rhythm, when a documented severe metabolic acidosis precedes the arrest — these are the scenarios where bicarb earns its place in the resuscitation. The physiological rationale is clear, the mechanism is targeted, and the evidence, while imperfect, supports its use in these defined circumstances.
Everywhere else — in the undifferentiated cardiac arrest, in the low-pH ABG that simply reflects the acidosis of shock, in the cannot-hurt default ordering pattern — bicarbonate adds insult to injury. It generates CO2 that cannot be cleared, drives intracellular acidosis in the organs you most need to protect, and provides false reassurance that you have addressed the chemistry when the real problem remains unaddressed.
Know the indications. Understand the physiology. Ask why before you push. That is what evidence-based resuscitation looks like in practice — and it is exactly the standard that every provider managing a code deserves to meet.
.jpg)
